--- title: "Earnings To Watch: Agilent (A) Reports Q2 Results Tomorrow" type: "News" locale: "en" url: "https://longbridge.com/en/news/296946476.md" description: "Agilent Technologies (A) is set to report Q2 earnings after market close tomorrow. Last quarter, the company beat revenue expectations with $1.84 billion in sales, up 10% year-over-year. For the current quarter, analysts expect 6% revenue growth. Peers like Avantor and Sotera Health have recently reported positive results, contributing to a 7.3% average sector gain. Agilent shares are up 12.4% over the last month, trading near its $160.89 analyst price target." datetime: "2026-08-25T18:14:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296946476.md) - [en](https://longbridge.com/en/news/296946476.md) - [zh-HK](https://longbridge.com/zh-HK/news/296946476.md) generator: "portal-rs" --- # Earnings To Watch: Agilent (A) Reports Q2 Results Tomorrow Life sciences tools company Agilent Technologies will be reporting results tomorrow after the bell. Here’s what investors should know. Agilent beat analysts’ revenue expectations last quarter, reporting revenues of $1.84 billion, up 10% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ organic revenue estimates and a narrow beat of analysts’ full-year EPS guidance estimates. Is Agilent a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, the market is expecting Agilent’s revenue to grow 6% year on year, slowing from the 10.1% increase it recorded in the same quarter last year. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Agilent rarely misses Wall Street’s revenue estimates. Looking at Agilent’s peers in the research tools & consumables segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Avantor posted flat year-on-year revenue, beating analysts’ expectations by 4.9%, and Sotera Health Company reported revenues up 9.2%, topping estimates by 3.8%. Avantor traded up 11.6% following the results while Sotera Health Company was also up 4.9%. Read our full analysis of Avantor’s results here and Sotera Health Company’s results here. There has been positive sentiment among investors in the research tools & consumables segment, with share prices up 7.3% on average over the last month. Agilent is up 12.4% during the same time and is heading into earnings with an average analyst price target of $160.89 (compared to the current share price of $154.98). **ALSO WORTH WATCHING: Nvidia’s Quiet Partner.** Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all. Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. ### Related Stocks - [AVTR.US](https://longbridge.com/en/quote/AVTR.US.md) - [SHC.US](https://longbridge.com/en/quote/SHC.US.md) - [A.US](https://longbridge.com/en/quote/A.US.md) - [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md) - [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md) ## Related News & Research - [Freestone Grove Partners LP Makes New Investment in Agilent Technologies, Inc. $A](https://longbridge.com/en/news/297159513.md) - [Piper Sandler Sticks to Its Hold Rating for Agilent (A)](https://longbridge.com/en/news/297181196.md) - [Agilent Technologies (NYSE:A) Announces Earnings Results](https://longbridge.com/en/news/297085075.md) - [Agilent Technologies raises annual forecast after Q3 results beat on strong demand](https://longbridge.com/en/news/297084372.md) - [36,589 Shares in Agilent Technologies, Inc. $A Purchased by Bamco Inc. NY](https://longbridge.com/en/news/297278864.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**